In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
about
Outbreak of Pseudomonas fluorescens bacteremia among oncology patientsIn vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.In vitro susceptibilities of Pseudomonas pseudomallei to 27 antimicrobial agents.In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrumEvaluation of the usefulness of a novel injectable cephalosporin, E1040, and ceftazidime for management of complicated urinary tract infections caused by Pseudomonas aeruginosa and Proteus mirabilis by using the rat urolithiasis modelCloning and characterization of the Pseudomonas aeruginosa pbpB gene encoding penicillin-binding protein 3.In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenemInteraction of E1040 with cephalosporinase from Citrobacter freundii GN7391.In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.
P2860
Q33678450-4E8A27D7-3590-4AD6-B2D6-1A778C9836A9Q35166038-86FD78DF-AE7A-453B-8B19-27545CE2F9E9Q35248754-99941C79-333A-4AC7-B86D-842AE3D6BF6DQ35255612-7CAFF615-060D-4191-9F86-B7021B954BCFQ35278735-4EE717DD-711C-4C91-B5ED-6368CDC38B13Q35565181-D5011651-12FB-4B11-A2C7-40CB5D921824Q35884688-A922F853-CAB9-46A7-8CA0-E303945884B1Q35885690-F7A8F0D3-9B38-4158-9B32-94C932AEACC4Q39780285-DED25C3E-50BB-473A-BFB9-118D84B471D2Q39781064-9E29B842-A65B-4CFA-94F8-329B0D776CB9Q39783613-C0E95615-A420-4966-BD0C-39FB866002F1Q39820513-B0B71F8F-C6B4-48C3-9057-DAFADE9BB204Q39875846-36248DA7-FFCA-48BB-BCFD-DF1F3B3A9E9DQ39875919-EDCA2985-CBF3-4064-8081-968A9C73682DQ39881805-3060437D-0E2D-43C4-9473-1025B5E5E3BDQ40088008-C4988EFC-EA0E-4F85-B8A8-30239ACAD56A
P2860
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
@en
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
@nl
type
label
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
@en
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
@nl
prefLabel
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
@en
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
@nl
P2093
P2860
P356
P1476
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.5.693
P407
P577
1988-05-01T00:00:00Z